Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Anal Biochem. 2010 Nov 10;410(1):133–140. doi: 10.1016/j.ab.2010.11.004

Table 2.

Screening results identifying inhibitors of SpHCS.

Compound Category # of Compounds
Total compounds in primary screen 40,879

Total hits (SD >3 or % inhibition >30%) 1665
Flagged cytoxic compounds −27a
Promiscuous compounds (SD > 3 in ≥ 10 previous screens) −216
Maleimide containing compounds −23

Total compounds in confirmation screen 1399 (3.4 %)

Total hits (median % inhibition > 30%) 595
Generally promiscuous compounds (> 30% inhibition in ≥ 10 previous screens) −67
Large compounds (topological polar surface area ≥ 140 Å2) −14
Compounds with limited availability −18

Total compounds for counter screens 496 (1.2 %)

Sulfhydryl-reacting or MMBC-CoA quenching compounds (% inhibition ≥ 30%) −54
Metal chelators (% inhibition < 30%) −81
8-hydroxyquinoline containing compounds −20
Compounds with limited availability −3

Total compounds analyzed for dose response 338 (0.8 %)

Total hits (compounds with sigmoidal dose response curves) 266
Compounds with pAC50 values <4.5 (IC50 >31.6 μM) −86
Compounds with Hill slope values <−2.0 −59

Compounds for follow-up studies 122 (0.3 %)
a

A minus (−) sign before the number indicates that the number of compounds eliminated from further consideration at this step.